Author:
Goñi Francisco J.,Barton Keith,Dias José António,Diestelhorst Michael,Garcia-Feijoo Julián,Hommer Anton,Kodjikian Laurent,Nicolò Massimo
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Bakri SJ, McCannel CA, Edwards AO, Moshfeghi DM. Persistent ocular hypertension following intravitreal ranibizumab. Graefes Arch Clin Exp Ophthalmol. 2008;246:955–8.
2. Bressler SB, Almukhtar T, Bhorade A, Diabetic Retinopathy Clinical Research Network Investigators, et al. Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment. JAMA Ophthalmol. 2015;133:589–97.
3. Reina-Torres E, Wen JC, Liu KC, et al. VEGF as a paracrine regulator of conventional outflow facility. Investig Ophthalmol Vis Sci. 2017;58:1899–1908 [Erratum in: Invest Ophthalmol Vis Sci. 2017;58:2817].
4. Lucentis summary of product characteristics. https://www.medicines.org.uk/emc/product/5418/smpc. Accessed 7 July 2021.
5. Eylea summary of product characteristics. https://www.medicines.org.uk/emc/product/11273/smpc. Accessed 7 July 2021.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献